IOCB Prague opened its new branch in Boston, USA on October 18, 2024. The move puts the institute in proximity to scientific institutions, such as Harvard University, MIT, and Boston Medical Center.

Researchers from IOCB Prague are furthering the understanding of how medicines work and what it takes to develop their most effective variants.

Even heavily modified double helices of DNA are stable enough to be used for special applications.

"I like the non-violence of the environmental chemistry field. We're trying to help society," says analytical chemist Martin Palušák from CXI TUL.

In the in Trends in Analytical Chemistry journal the researchers from the Institute of Physiology of the Czech Academy of Sciences, gave comprehensive overview of metabolomics and lipidomics tools.

Scientists from Dr. Lenka Maletinska's team have developed a new substance that may help to solve the health limitations of obesity and Alzheimer's disease.

Our laboratory is equipped with high-end mass spectrometry instruments, which offers services in field of PROTEOMICS and METABOLOMICS.

A research group led by Dr. Edward Curtis has developed two new types of catalytic DNA molecules (deoxyribozymes) that can reveal the presence of target molecules through fluorescence or color.

Technology from the laboratories of IOCB Prague has been given an extraordinary opportunity to succeed in the rapidly developing segment of gene therapy.

Pavel Hobza from the IOCB Prague and his team discovered improper hydrogen bond twenty years ago. Current discovery has the potential to simplify the previously adopted definition of the hydrogen bond.